Center for Advanced Preclinical Imaging (CAPI)

What Center for Advanced Preclinical Imaging (CAPI) does

CAPI (Centrum pokročilého preklinického zobrazování / Center for Advanced Preclinical Imaging) is a non-profit preclinical imaging research facility housed within the First Faculty of Medicine at Charles University in Prague, established in 2016 with support from the Czech Ministry of Education's OP VaVpI programme. It operates a portfolio of complementary in vivo imaging modalities for small laboratory animals (mice and rats), spanning anatomical methods (7T MRI, 1T MRI, CT, high-frequency ultrasound) and molecular methods (PET, SPECT, magnetic particle imaging, bioluminescence/fluorescence, photoacoustics), together with imaging flow cytometry. Together, this instrument base is described as the only comprehensive multimodal preclinical imaging capability of its kind in Central Europe under a single roof.

The facility serves three primary user groups: academic research teams running grant-funded preclinical studies, clinical research teams developing and validating imaging biomarkers for translational work, and industrial partners (pharmaceutical, biotech, medical device) requiring contract imaging services. Distribution is governed by the Open Access frameworks of Czech-BioImaging (national) and Euro-BioImaging (European), which mandate user registration, standardized protocols, and infrastructure acknowledgment in publications. Pricing is quote-based via the head of department rather than published.

The business model is service-based (professional services) and Open Access, but commercial fees are not the primary funding source. Operating sustainability is anchored in public grants (Czech Ministry of Education LM2023050 running 2023-2026; prior LM2015062, EF16_013/0001775, EF18_046/0016045 from the European Regional Development Fund), institutional support from Charles University, and co-funded research projects with the Czech Science Foundation, Technology Agency of the Czech Republic, and Ministry of Health. CAPI holds three granted patents in nanoparticle contrast agent chemistry and has contributed to over 100 peer-reviewed publications across journals including Nature Communications, Magnetic Resonance in Medicine, and ACS Applied Materials.

Name

Center for Advanced Preclinical Imaging (CAPI)

Legal name

Centrum pokročilého preklinického zobrazování

Website

https://capi.lf1.cuni.cz

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

CAPI is a non-profit preclinical imaging facility at Charles University's First Faculty of Medicine in Prague, providing multimodal in vivo imaging of small laboratory animals to academic, clinical, and industrial researchers via Czech-BioImaging and Euro-BioImaging Open Access.

Ownership category

akta.pro rank

Product category

Preclinical Imaging Services

NAICS

Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Nanotechnology (541713)

SIC

Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)

akta.pro industry

PRIMARYHLAMADAA

Reference Laboratory Testing (Clinical Pathology & Chemistry)

Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)

SECONDARYHDAAAEAH

Medical Imaging AI

Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/Computer Vision & Video Analytics

SECONDARYHLAAANAF

Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics)

Healthcare & Life Sciences/Biotechnology & Biologics/Precision Medicine Solutions

SECONDARYHLAFAKAB

Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology)

Healthcare & Life Sciences/Healthcare Providers & Systems/Diagnostic & Imaging Centers

Keywords

• Preclinical imaging
• Multimodal imaging
• Small animal imaging
• Molecular imaging services
• Biomedical research infrastructure

Headquarters

HQ city

Prague

HQ country

Czechia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Others

Revenue model

1. Preclinical Imaging Services: Service-based revenue from providing preclinical imaging access to academic, clinical, and industrial researchers. Operates under Open Access model through Czech-BioImaging and Euro-BioImaging research infrastructures, providing standardized access protocols.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

CAPI is a university research facility that provides multimodal preclinical in vivo imaging services for small laboratory animals (mice and rats). The facility integrates anatomical imaging modalities (MRI at 1T and 7T, CT, high-frequency ultrasound) with molecular imaging methods (PET, SPECT, optical bioluminescence/fluorescence, magnetic particle imaging, photoacoustics) under one roof. Services are delivered via Open Access through Czech-BioImaging and Euro-BioImaging research infrastructures to academic, clinical, and industrial researchers.

Product overview

CAPI is a research facility providing a comprehensive portfolio of preclinical in vivo imaging modalities for small laboratory animals. The core offering includes multiple complementary imaging technologies: high-field 7T MRI and 1T ICON MRI scanners for anatomical and functional imaging; Albira CT/PET/SPECT for multimodal nuclear imaging; MPI magnetic particle imaging for quantitative nanoparticle tracking; Bruker Xtreme for optical bioluminescence and fluorescence imaging; VEVO LAZR-X for ultrasound and photoacoustic imaging; and AMNIS ImageStream for imaging flow cytometry. CAPI offers open access to these technologies through Czech-BioImaging and Euro-BioImaging infrastructures, serving academic, clinical, and industrial researchers in preclinical biomedical studies.

Differentiator

Problem solved

Functional benefit

Products and services

• In Vivo Preclinical Imaging Services
• 7T MRI Imaging Service
• ICON 1T MRI Imaging Service
• Albira CT/PET/SPECT Imaging Service
• Magnetic Particle Imaging (MPI) Service
• Bruker Xtreme Optical Imaging Service
• VEVO LAZR-X Ultrasound/Photoacoustic Imaging Service
• AMNIS ImageStream Imaging Flow Cytometry Service

Quantifiable outcome

• Established 2016, operating continuously providing services to Czech and international researchers

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature7 records

Partnerships

Six partnerships are on record, tiered core, major and minor.

• Czech-BioImagingcoreStrategic or Co-development Partner · 1 January 2016CAPI is a founding member and core facility of Czech-BioImaging, the national research infrastructure for biological and medical imaging. This partnership enables Open Access to CAPI services for Czech researchers through standardized protocols and user registration systems.
• Euro-BioImagingcoreStrategic or Co-development Partner · 1 January 2016CAPI holds node status in the Euro-BioImaging European consortium, enabling provision of services to international users through the Open Access system. This partnership extends CAPI's reach across Europe.
• Czech Academy of Sciences - Institute of Macromolecular ChemistrymajorStrategic or Co-development PartnerLong-standing collaboration with multiple departments including Polymer Particles, Biomedical Polymers, and Bioactive Polymers groups. Joint research in polymer-based contrast agents and nanoparticles.
• Institute of Experimental Medicine (IEM)majorStrategic or Co-development PartnerCollaboration with Neuroregeneration Department on stem cell tracking and neural tissue regeneration imaging studies.
• SOTIO a.s.minorStrategic or Co-development PartnerCollaboration with Czech biotechnology company on preclinical oncology imaging studies for drug development.
• Charles University - First Faculty of MedicinecoreStrategic or Co-development PartnerCAPI is an integral part of the First Faculty of Medicine, providing institutional support, administrative services, and integration with broader academic research programs.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Market position

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/imaging-capi
• Instagraminstagram.com/capi_lf1

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Center for Advanced Preclinical Imaging (CAPI)